Jim Simons started to build up the position in XBiotech in Q2 2022 and continued to invest until Q3 2022. Since then they sold 155 Thousand shares. The investor completely sold their stake between Q4 2022 and Q4 2023.
Avg closing price
Price range
Sold -15.3 Thousand shares
Q4 2023
Avg closing price
$3.98
Price range
$3.56
-
$4.65
Sold 46.0% shares (-13 Thousand shares)
Q3 2023
Avg closing price
$5.00
Price range
$4.02
-
$5.81
Sold 46.0% shares (-24.2 Thousand shares)
Q2 2023
Avg closing price
$4.51
Price range
$3.06
-
$6.38
Sold 48.3% shares (-49 Thousand shares)
Q1 2023
Avg closing price
$3.73
Price range
$3.22
-
$4.72
Sold 34.7% shares (-54 Thousand shares)
Q4 2022
Avg closing price
$3.41
Price range
$3.03
-
$3.79
Increased shares by 97.6% (+76.8 Thousand shares)
Q3 2022